Published in J Immunol on December 15, 1997
Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun (2002) 1.45
Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect Immun (1998) 1.31
Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Infect Immun (2006) 1.25
DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene. Infect Immun (2001) 1.24
Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection. Infect Immun (2006) 1.20
Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect Immun (2002) 1.18
Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection. Infect Immun (2003) 1.15
Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection. Infect Immun (2005) 1.13
Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene. Infect Immun (1999) 1.13
Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen. Infect Immun (2005) 1.13
Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi. Infect Immun (2007) 1.05
Regulation of CD8+ T cell responses to infection with parasitic protozoa. Exp Parasitol (2010) 1.04
Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. J Clin Invest (1998) 1.01
Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi. PLoS Negl Trop Dis (2011) 0.99
Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy. Infect Immun (2002) 0.99
DNA Vaccines against Protozoan Parasites: Advances and Challenges. J Biomed Biotechnol (2007) 0.95
Most parasite-specific CD8+ cells in Trypanosoma cruzi-infected chronic mice are down-regulated for T-cell receptor-alphabeta and CD8 molecules. Immunology (2001) 0.87
Immunization of mice with a TolA-like surface protein of Trypanosoma cruzi generates CD4(+) T-cell-dependent parasiticidal activity. Infect Immun (1999) 0.86
Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation. J Immunol (2011) 0.86
Evasion of the Immune Response by Trypanosoma cruzi during Acute Infection. Front Immunol (2016) 0.84
Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection. PLoS Negl Trop Dis (2014) 0.84
An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes. Hum Vaccin Immunother (2015) 0.82
Genetic immunization converts the trypanosoma cruzi B-Cell mitogen proline racemase to an effective immunogen. Infect Immun (2009) 0.82
CD8+ T cells in Trypanosoma cruzi infection. Semin Immunopathol (2015) 0.80
Interleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8+ T cell responses against a HBV DNA vaccine in mice. Hum Vaccin Immunother (2013) 0.80
Th17 Cells Are More Protective Than Th1 Cells Against the Intracellular Parasite Trypanosoma cruzi. PLoS Pathog (2016) 0.76
CD8(+) T Cell Responses to Plasmodium and Intracellular Parasites. Curr Immunol Rev (2013) 0.76
A Brief View of the Surface Membrane Proteins from Trypanosoma cruzi. J Parasitol Res (2017) 0.76
Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells. Infect Immun (2016) 0.75
Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity. PLoS Pathog (2016) 0.75
Differential phenotypic and functional profiles of TcCA-2 -specific cytotoxic CD8+ T cells in the asymptomatic versus cardiac phase in Chagasic patients. PLoS One (2015) 0.75
Combinatorial chemoprevention of intestinal neoplasia. Nat Med (2000) 3.66
The Trypanosoma cruzi proteome. Science (2005) 2.63
Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol (2002) 2.03
Physical mapping of the split hand/split foot locus on chromosome 7 and implication in syndromic ectrodactyly. Hum Mol Genet (1994) 1.86
Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J Infect Dis (1999) 1.84
Nucleotide sequences and phylogeny of the nucleocapsid gene of Oropouche virus. J Gen Virol (2000) 1.70
Restoration of in vitro immune responses of spleen cells from mice infected with Trypanosoma cruzi by supernatants containing interleukin 2. J Immunol (1984) 1.53
Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3-q22.1. Am J Hum Genet (1994) 1.48
Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect Immun (1998) 1.31
The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol (1998) 1.31
Antigen-specific Th1 but not Th2 cells provide protection from lethal Trypanosoma cruzi infection in mice. J Immunol (2001) 1.22
Persistent production of inflammatory and anti-inflammatory cytokines and associated MHC and adhesion molecule expression at the site of infection and disease in experimental Trypanosoma cruzi infections. Exp Parasitol (1996) 1.21
Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL. J Immunol (1998) 1.21
Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. J Immunol (1997) 1.20
Characterization of cytokine production in murine Trypanosoma cruzi infection by in situ immunocytochemistry: lack of association between susceptibility and type 2 cytokine production. Eur J Immunol (1996) 1.20
Predominance of CD8+ T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am J Trop Med Hyg (1993) 1.18
Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection. J Immunol (1991) 1.12
Deletions of distal 9p associated with 46,XY male to female sex reversal: definition of the breakpoints at 9p23.3-p24.1. Genomics (1997) 1.10
Trypanosoma cruzi: cytokine effects on macrophage trypanocidal activity. Exp Parasitol (1991) 1.10
Feline Leishmania infection in a canine leishmaniasis endemic region, Portugal. Vet Parasitol (2010) 1.02
Changes in cell populations and immunoglobulin-producing cells in the spleens of mice infected with Trypanosoma cruzi: correlations with parasite-specific antibody response. Cell Immunol (1983) 1.01
The BAT1 gene in the MHC encodes an evolutionarily conserved putative nuclear RNA helicase of the DEAD family. Genomics (1995) 0.99
Measurement of parasite-specific immune responses in vitro: evidence for suppression of the antibody response to Trypanosoma cruzi. Eur J Immunol (1985) 0.99
The identification and molecular characterization of Trypanosoma cruzi amastigote surface protein-1, a member of the trans-sialidase gene super-family. Mol Biochem Parasitol (1997) 0.95
Demonstration of IgG-Fc and C3 receptors on adult Schistosoma mansoni. J Immunol (1981) 0.95
Molecular cloning of the gene encoding the 83 kDa amastigote surface protein and its identification as a member of the Trypanosoma cruzi sialidase superfamily. Mol Biochem Parasitol (1997) 0.95
Proteins with glycosylphosphatidylinositol (GPI) signal sequences have divergent fates during a GPI deficiency. GPIs are essential for nuclear division in Trypanosoma cruzi. J Biol Chem (1997) 0.94
Trypanosoma cruzi: effect on B-cell-responsive and -responding clones. Exp Parasitol (1981) 0.94
Failure of testicular development associated with a rearrangement of 9p24.1 proximal to the SNF2 gene. Hum Genet (1998) 0.90
Sequential combined treatment with allopurinol and benznidazole in the chronic phase of Trypanosoma cruzi infection: a pilot study. J Antimicrob Chemother (2012) 0.89
Infectivity of five different types of macrophages by Leishmania infantum. Acta Trop (2007) 0.88
Swyer syndrome and 46,XY partial gonadal dysgenesis associated with 9p deletions in the absence of monosomy-9p syndrome. Am J Hum Genet (1998) 0.88
Glycosylphosphatidylinositols are required for the development of Trypanosoma cruzi amastigotes. Infect Immun (1997) 0.87
Diagnosis of recent Toxoplasma gondii infection in cats by use of an enzyme-linked immunosorbent assay for immunoglobulin M. Am J Vet Res (1989) 0.87
Construction and use of a multi-competitor gene for quantitative RT-PCR using existing primer sets. J Immunol Methods (1995) 0.86
Trypanosoma cruzi infection suppresses nuclear factors that bind to specific sites on the interleukin-2 enhancer. Eur J Immunol (1994) 0.86
Analysis of the Trypanosoma cruzi cyclophilin gene family and identification of Cyclosporin A binding proteins. Parasitology (2006) 0.85
Endotoxin-induced tumor necrosis factor activity production by equine peritoneal macrophages. Circ Shock (1990) 0.84
Selective suppressive effects of Trypanosoma cruzi infection on IL-2, c-myc, and c-fos gene expression. J Immunol (1992) 0.84
The Casiquiare river acts as a corridor between the Amazonas and Orinoco river basins: biogeographic analysis of the genus Cichla. Mol Ecol (2010) 0.84
Is it advantageous to lower cholesterol in the elderly hypertensive? Cardiovasc Drugs Ther (2000) 0.83
Effects of extracts of Trypanosoma cruzi on immune responses: induction of a nonspecific suppressor factor. Infect Immun (1983) 0.83
Report of the Third International Workshop on Human Chromosome 8 Mapping. San Antonio, Texas, October 25-27, 1996. Cytogenet Cell Genet (1996) 0.81
In vitro culture of cardiac mast cells from mice experimentally infected with Trypanosoma cruzi. Int Arch Allergy Immunol (1994) 0.81
Enzyme-linked immunosorbent assay for the detection of circulating antigens of Toxoplasma gondii in the serum of cats. Am J Vet Res (1989) 0.81
Mapping and genetic organization of the TNF genes in the swine Mhc. Immunogenetics (1991) 0.79
Measurement of parasite-specific antibody responses using a tritiated avidin-solid phase radioimmunoassay. J Immunol Methods (1983) 0.79
Diagnosis of Oropouche virus infection using a recombinant nucleocapsid protein-based enzyme immunoassay. J Clin Microbiol (2001) 0.79
Trypanosomes and microfilariae in feral owl and squirrel monkeys maintained in research colonies. Am J Trop Med Hyg (1993) 0.78
Diagnosis of Chagas' disease in humans using a biotin-3H-avidin radioimmunoassay. Am J Trop Med Hyg (1984) 0.78
Loss of suppressor activity in the serum of mice infected with Trypanosoma cruzi. J Parasitol (1984) 0.78
Hypertelorism and hypospadias associated with a de novo apparently balanced translocation between 8q22.3-23 and 20p13. Am J Med Genet (1997) 0.77
A monoclonal antibody to alpha tubulin recognizes host cell and Trypanosoma cruzi tubulins. J Protozool (1988) 0.76
Treatment of oral condylomata acuminata in a HIV-1 patient with bleomycin. J Eur Acad Dermatol Venereol (2000) 0.75
Mitomycin C-treated Trypanosoma cruzi in vaccination of mice: induction of immunosuppression but not protection. Infect Immun (1981) 0.75
Differentiation of trypanosomatid species by hybridization to selected rRNA probes. Mol Cell Probes (1993) 0.75
[Sex determination and differentiation in man: from pathology to genes]. Arch Pediatr (1997) 0.75
Comparative study of Klebsiella oxytoca and Klebsiella pneumoniae isolates in a general hospital. Isr J Med Sci (1992) 0.75
Optimization of dengue virus genome assembling using GSFLX 454 pyrosequencing data: evaluation of assembling strategies. Genet Mol Res (2012) 0.75
A new liquid chromatography/tandem mass spectrometric approach for the identification of class I major histocompatibility complex associated peptides that eliminates the need for bioassays. Rapid Commun Mass Spectrom (1999) 0.75
[Evaluation of interests, experiences and chemistry knowledge among students admitted to the Lisboa Medical School en 1989/1990]. Acta Med Port (1991) 0.75
Dinucleotide repeat polymorphism at the porcine TNFA locus. Anim Genet (1995) 0.75
Retrieval effects of both post- and presession beta-endorphin administration in a three-session paradigm. Pharmacol Biochem Behav (1990) 0.75
[Management of tricuspid atresia in neonates. Report of three cases and review of literature]. J Pediatr (Rio J) (2003) 0.75
Ipomeanol analogs as chemopreventive agents: effect on the in vitro metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Cancer Lett (1995) 0.75
Biology of tegument associated IgG-Fc and C3 receptors inSchistosoma mansoni. J Chem Ecol (1986) 0.75
Atmospheric impact assessment and monitoring of dioxin emissions of municipal solid waste incinerators in Portugal. Chemosphere (1999) 0.75